Search results
Results from the WOW.Com Content Network
Business analysis is a professional discipline [1] focused on identifying business needs and determining solutions to business problems. [2] Solutions may include a software-systems development component, process improvements, or organizational changes, and may involve extensive analysis, strategic planning and policy development.
In healthcare, business analysis can be used to operate and manage clinical information systems. It can transform medical data from a bewildering array of analytical methods into useful information. Data analysis can also be used to generate contemporary reporting systems which include the patient's latest key indicators, historical trends and ...
A business analyst should have knowledge in IT and/or business, but the combination of both of these fields is what makes a business analyst such a valuable asset to the business environment. As a minimum standard, a business analyst should have a "general understanding of how systems, products and tools work" in the business environment. [2]
Business Analysis and Valuation Using Financial Statements: Text and Cases [2] is a textbook by Krishna Palepu and Paul Healy, which is widely used in worldwide MBA programs and finance courses. It is in its 5th edition, and also has an IFRS edition. [3] The fifth edition was released August 2012. [1]
Every investor in VBI Vaccines Inc. ( NASDAQ:VBIV ) should be aware of the most powerful shareholder groups. Generally...
The race to bring a COVID-19 vaccine to market is far from over. There are several companies vying for first place, with these names representing Big Pharma as well as the smaller end of the ...
“The Trueblood Report: An Analyst's View.” Financial Analysts Journal, vol. 31, no. 1, 1975, pp. 32–56. JSTOR 4477781. American Institute of Certified Public Accountants. Study Group on the Objectives of Financial Statements. Objectives of financial statements: Report of the Study Group on the Objectives of Financial Statements. 1973 ...
VBI Vaccines' (NASDAQ:VBIV) stock is on the move. The shares have rallied on the heels of a successful clinical trial. But is it too late to buy the stock?While VBIV has soared around 130% since ...